Related Experiment Video
Updated: May 22, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Frequency of Culture-proven Bacterial Infection and Radiographic Pneumonia in Pediatric Heart Transplant Recipients
Melisa S Tanverdi1, Tamar R Lubell2, Melanie D Everitt3
1From the Section of Pediatric Emergency Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.
Insights
Infections are a major risk for pediatric heart transplant recipients. Over 15% of suspected infections were bacterial or pneumonia, but clinical signs were not reliable predictors.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Transplant Medicine
Background:
- Infection is a significant cause of mortality following pediatric heart transplants (PHTs).
- Understanding common pathogens is crucial for optimizing diagnostic strategies and empirical antibiotic administration in PHT patients.
Purpose of the Study:
- To investigate the incidence and characteristics of culture-proven bacterial infections and radiographic pneumonia in pediatric heart transplant recipients presenting with suspected infections.
- To identify clinical and laboratory predictors of bacterial infection or pneumonia in this vulnerable population.
Main Methods:
- A retrospective study was conducted across three centers, analyzing data from pediatric heart transplant recipients (≤18 years) from 2010 to 2018.
- Suspected infections were defined by fever, elevated temperature, or blood culture acquisition within two years post-transplant.
- Primary outcomes included culture-proven bacterial infection or radiographic pneumonia; secondary outcomes involved septic shock, antibiotic resistance, and viral infections.
Main Results:
- Out of 193 children, 108 (56.0%) experienced at least one suspected infection encounter.
- Culture-proven bacterial infection or radiographic pneumonia occurred in 15.5% of 258 encounters, with 88.8% managed in the emergency department.
- Clinical and laboratory findings were similar between patients with and without confirmed bacterial infection or pneumonia, indicating limited predictive value.
Conclusions:
- Pediatric heart transplant recipients with suspected infections have a substantial risk (over 15%) of culture-proven bacterial infection or radiographic pneumonia.
- The lack of distinct clinical or laboratory markers highlights challenges in early identification.
- Standardizing diagnostic approaches may improve the detection of infections and support antimicrobial stewardship efforts.
Background:
Infection is a leading cause of death after pediatric heart transplants (PHTs). Understanding of common pathogens is needed to guide testing strategies and empiric antibiotic use.
Methods:
We conducted a 3-center retrospective study of PHT recipients ≤18 years old presenting to cardiology clinics or emergency departments (EDs) from 2010 to 2018 for evaluation of suspected infections within 2 years of transplant. Suspected infection was defined as (1) chief complaint of fever and/or (2) visit temperature ≥38 °C, and/or (3) blood culture obtained. The primary outcome was a culture-proven bacterial infection or radiographic pneumonia. Secondary outcomes included fluid-refractory septic shock, antibiotic resistance, respiratory viral infections and diagnostic testing. The unit of analysis was the encounter.
Results:
Of 193 children meeting inclusion criteria, 108 (56.0%) had ≥1 visit for suspected infection. Of 258 total encounters, 88.8% occurred in the ED and 52.8% resulted in admission. Culture-proven bacterial infection (4.3%) or radiographic pneumonia (11.6%) was documented in 15.5% of encounters; 1 (0.4%) had bacteremia. Antibiotics were administered in 33.7% of encounters, and 3 (1.2%) required inotropic support for fluid-refractory shock. Viral testing was sent in 162 encounters (62.8%), and 52% detected viral pathogens. Clinical characteristics and routinely obtained laboratory testing were similar in encounters with and without culture-proven bacterial infection or radiographic pneumonia.
Conclusions:
Over 15% of PHT recipients presenting with suspected infection had culture-proven bacterial infection or radiographic pneumonia. No single clinical or laboratory variable accurately identified these patients, potentially due to variability in testing. A more standardized approach could augment diagnostic and antimicrobial stewardship.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...

